Plx Pharma Inc (PLXP) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Plx Pharma Inc   (NASDAQ: PLXP)


Plx Pharma Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Plx Pharma Inc 's ROA in the third quarter of 2022?
Plx Pharma Inc recorded a cumulative net loss of $-25 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -47.25%.

However, within the Healthcare sector 737 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 4822, from total ROA ranking in the second quarter of 2022 at 5083.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Total Assets Change -63.72 % -47.79 % -31.13 % 190.66 % 607.29 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -25 -39 -43 -44 -57
Return On Assets (TTM) -47.25 % -56.4 % -55 % -51.09 % -78.06 %
PLXP's Total Ranking # 4822 # 5083 # 5028 # 5327 # 4607
Total Assets (TTM) in million 33 45 61 76 92
Seq. Total Assets Change -25.41 % -26.57 % -20.62 % -16.56 % 7.35 %
Seq. Net Income Change - - - - -

PLXP's 5 Years Annual ROA >> Back to PLXP Management Effectiveness >> Compare PLXP ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 325
Sector # 738
Overall # 4722

Return On Assets Statistics
High Average Low
55.25 %
-40.22 %
-88.22 %
(Jun 30 2020)   (Jun 30 2019)





Financial Statements
Plx Pharma Inc 's Assets $ 33 million PLXP's Balance sheet
Plx Pharma Inc 's Income $ -8 million Quarterly PLXP's Income Statement
PLXP's Income by Division See PLXP's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change 190.66 % 42.08 % 0.62 % -36.26 % 68.8 %
Total Assets in million 76 26 19 18 29
Y / Y Net Income Change - - - - -
Net Income in million -44 -13 -7 1 -15
Annual Return On Assets -57.06 % -51.25 % -36.49 % 4.88 % -53.2 %

PLXP's 5 Years Annual ROA >> Back to PLXP Management Effectiveness >> Compare PLXP ROA to its Competitors



More Return On Assets Ratios
PLXP's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PLXP's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PLXP's Competitors
Subscribers only: Roa for Plx Pharma Inc 's Suppliers
Subscribers only: Return On Assets for PLXP's Customers

You may also want to know
PLXP's Roi PLXP's Inventory Turnover Ratio PLXP's Growth Rates PLXP's Dividend Comparisons
PLXP's Profitability Ratios PLXP's Asset Turnover Ratio PLXP's Dividend Growth
PLXP's Roe PLXP's Valuation Ratios PLXP's Financial Strength Ratios PLXP's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:46+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.